XML 142 R30.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2024
Equity [Abstract]  
Schedule of Stock Option Activity
Stock option activity in 2024 for employee and non-employee awards and related information is as follows (in thousands, except per share and contractual term data):
Number of Outstanding OptionsWeighted-
Average
Exercise
Price Per
Share
Weighted-
Average
Remaining
Contractual
Term
(in years)
Aggregate
Intrinsic
Value
Balance at December 31, 202312,495$14.91 
Granted4,16227.06 
Exercised(3,498)13.78 
Forfeited/expired(524)15.70 
Balance at December 31, 202412,635$19.19 7.88$149,957 
Vested and expected to vest at December 31, 202412,635$19.19 7.88$149,957 
Exercisable at December 31, 20245,772$15.32 6.89$79,900 
The following summarizes additional information regarding stock options (in thousands, except per share data):
Year Ended December 31,
202420232022
Cash received from options exercised$48,207 $573 $470 
Intrinsic value of options exercised$83,422 $2,421 $6,724 
Weighted-average grant date fair value per share$19.26 $10.33 $11.11 
Schedule of Unvested Restricted Stock Units Roll Forward
The following table summarizes the RSU activity for the year ended December 31, 2024 (in thousands, except per share data):
Number of SharesWeighted-Average Grant Date Fair Value
Balance at December 31, 2023758 $18.73 
Granted1,711 25.51 
Vested(184)18.79 
Forfeited(174)14.82 
Balance at December 31, 20242,111 $24.54 
The following table summarizes the PSU activity for the year ended December 31, 2024 (in thousands, except per share data):
Number of SharesWeighted-Average Grant Date Fair Value
Balance at December 31, 2023750 $6.57 
Granted738 43.22 
Vested(563)6.57 
Forfeited— — 
Balance at December 31, 2024925 $35.80 
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions
The assumptions used in the Black-Scholes model to determine the fair value of stock option grants and shares purchasable under the ESPP were as follows:
OptionsESPP
Year Ended December 31,Year Ended December 31,
202420232022202420232022
Risk-free interest rate
3.5% - 4.7%
3.5% - 4.9%
1.5% - 4.2%
4.3% - 5.4%
5.4%
2.2% - 4.7%
Expected volatility
79% - 82%
78% - 82%
85%
64% - 82%
68% - 76%
78% - 79%
Expected term (in years)
5.3 - 6.1
5.5 - 6.1
5.5 - 6.1
0.50.50.5
Expected dividend yield—%—%—%—%—%—%
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions
The assumptions used in the Black-Scholes model to determine the fair value of stock option grants and shares purchasable under the ESPP were as follows:
OptionsESPP
Year Ended December 31,Year Ended December 31,
202420232022202420232022
Risk-free interest rate
3.5% - 4.7%
3.5% - 4.9%
1.5% - 4.2%
4.3% - 5.4%
5.4%
2.2% - 4.7%
Expected volatility
79% - 82%
78% - 82%
85%
64% - 82%
68% - 76%
78% - 79%
Expected term (in years)
5.3 - 6.1
5.5 - 6.1
5.5 - 6.1
0.50.50.5
Expected dividend yield—%—%—%—%—%—%
Schedule of Allocated Stock-based Compensation Expense
The allocation of stock-based compensation expense was as follows (in thousands):
Year Ended December 31,
202420232022
Research and development expense$26,120 $22,007 $15,222 
General and administrative expense25,243 16,215 11,917 
Total stock-based compensation expense$51,363 $38,222 $27,139